Канал: CLINUVEL

CLINUVEL 2024 Annual General Meeting

CLINUVEL 2024 Annual General Meeting

CLINUVEL FY2024 Financial Results Webinar

CLINUVEL FY2024 Financial Results Webinar

Sydney Capital Markets Briefing: Vitiligo

Sydney Capital Markets Briefing: Vitiligo

Sydney Capital Markets Briefing: R&D pipeline

Sydney Capital Markets Briefing: R&D pipeline

Sydney Capital Markets Briefing: Commercial Update

Sydney Capital Markets Briefing: Commercial Update

Sydney Capital Markets Briefing: Chair’s address

Sydney Capital Markets Briefing: Chair’s address

CLINUVEL Share Buy-back, 14 March 2024

CLINUVEL Share Buy-back, 14 March 2024

CLINUVEL Investor Webinar for half year results ending 31 December 2023

CLINUVEL Investor Webinar for half year results ending 31 December 2023

CLINUVEL PHARMACEUTICALS LTD — Annual General Meeting 2023

CLINUVEL PHARMACEUTICALS LTD — Annual General Meeting 2023

CLINUVEL Pharmaceuticals - Annual General Meeting 2022

CLINUVEL Pharmaceuticals - Annual General Meeting 2022

Susannah Streeter and Philippe Wolgen. Part 3 of 3: Values and vision

Susannah Streeter and Philippe Wolgen. Part 3 of 3: Values and vision

CUV151 DNA Repair Study Update

CUV151 DNA Repair Study Update

Susannah Streeter and Philippe Wolgen. Part 2 of 3: Differentiating CLINUVEL in the biotech industry

Susannah Streeter and Philippe Wolgen. Part 2 of 3: Differentiating CLINUVEL in the biotech industry

Susannah Streeter and Philippe Wolgen. Part 1 of 3: Navigating uncertainty

Susannah Streeter and Philippe Wolgen. Part 1 of 3: Navigating uncertainty

CLINUVEL — update on EPP treatment in England

CLINUVEL — update on EPP treatment in England

CLINUVEL Operational Update

CLINUVEL Operational Update

Dr Pilar Bilbao — CLINUVEL’s DNA Repair Program

Dr Pilar Bilbao — CLINUVEL’s DNA Repair Program

Dr Jessica Nucci — afamelanotide in xeroderma pigmentosum (XP), DNA damage & repair

Dr Jessica Nucci — afamelanotide in xeroderma pigmentosum (XP), DNA damage & repair

CLINUVEL 2022 Financial Results Investor Webinar

CLINUVEL 2022 Financial Results Investor Webinar

CLINUVEL: developing innovative treatments for stroke patients

CLINUVEL: developing innovative treatments for stroke patients

A CLINUVEL Webcast on Market Position, Financial Management and Growth

A CLINUVEL Webcast on Market Position, Financial Management and Growth

Operations Update I – 2022 Financial Results Webinar

Operations Update I – 2022 Financial Results Webinar

Dr Pilar Bilbao - Update on CLINUVEL's DNA Repair Program - Part 2

Dr Pilar Bilbao - Update on CLINUVEL's DNA Repair Program - Part 2

Dr Pilar Bilbao - Update on CLINUVEL's DNA Repair Program - Part 1

Dr Pilar Bilbao - Update on CLINUVEL's DNA Repair Program - Part 1

Dr Pilar Bilbao – Update on CLINUVEL’s Stroke Program

Dr Pilar Bilbao – Update on CLINUVEL’s Stroke Program

CLINUVEL management discuss Quarterly Cash Flow Statement - 31 January 2022

CLINUVEL management discuss Quarterly Cash Flow Statement - 31 January 2022

Insider Insights: Dr Philippe Wolgen, Shaping Our Culture

Insider Insights: Dr Philippe Wolgen, Shaping Our Culture

CLINUVEL AGM - 2021

CLINUVEL AGM - 2021

CLINUVEL at Morgans Scone Value in the Vines Investor Conference 2021

CLINUVEL at Morgans Scone Value in the Vines Investor Conference 2021

CLINUVEL Investor Webinar

CLINUVEL Investor Webinar

CLINUVEL Operations Update Webcast II

CLINUVEL Operations Update Webcast II

CLINUVEL Investor Webinar FY2021 Results

CLINUVEL Investor Webinar FY2021 Results

Dr Pilar Bilbao on CLINUVEL's Stroke Trials

Dr Pilar Bilbao on CLINUVEL's Stroke Trials

CLINUVEL - What is a Stroke?

CLINUVEL - What is a Stroke?

Willem Blijdorp Insider Insights III: Challenges & the Future

Willem Blijdorp Insider Insights III: Challenges & the Future

Insider Insights II: Willem Blijdorp, CLINUVEL’s Products, People & Social Purpose

Insider Insights II: Willem Blijdorp, CLINUVEL’s Products, People & Social Purpose

Insider Insights: Willem Blijdorp, Chair in a public company

Insider Insights: Willem Blijdorp, Chair in a public company

We are CLINUVEL

We are CLINUVEL